4//SEC Filing
KOVEN ANDREW I 4
Accession 0001104659-24-069786
CIK 0001638287other
Filed
Jun 6, 8:00 PM ET
Accepted
Jun 7, 7:25 PM ET
Size
5.9 KB
Accession
0001104659-24-069786
Insider Transaction Report
Form 4
KOVEN ANDREW I
Director
Transactions
- Award
Common Stock
2024-06-07+5,051→ 17,552 total
Footnotes (2)
- [F1]Represents a grant of restricted stock units ("RSUs") issued to the Reporting Person under the Issuer's 2022 Equity Incentive Plan, which vests on the earlier of June 7, 2025 or the day immediately prior to the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continuing service on the applicable vesting date. In accordance with the terms of the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the "Policy"), the Reporting Person elected to defer receipt of the shares of common stock upon the vesting of the RSUs until the earlier of the date that is (i) immediately prior to a Change in Control (as described in the Policy), or (ii) within 60 days following the Reporting Person's retirement or other separation from service with the Issuer or death, whichever is earlier.
- [F2]The total number of securities beneficially owned has been adjusted to reflect the Issuer's completion of a 1-for-8 reverse stock split on December 20, 2023.
Documents
Issuer
NeuroBo Pharmaceuticals, Inc.
CIK 0001638287
Entity typeother
Related Parties
1- filerCIK 0001258673
Filing Metadata
- Form type
- 4
- Filed
- Jun 6, 8:00 PM ET
- Accepted
- Jun 7, 7:25 PM ET
- Size
- 5.9 KB